[LGND] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 388.63%
YoY- 372.66%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 28,101 32,868 26,366 43,979 50,382 66,088 57,419 -37.81%
PBT 17,097 -15,344 3,171 55,536 24,140 857 -636 -
Tax -1,091 -2,552 881 11,922 38,674 453 259 -
NP 18,188 -12,792 2,290 41,949 -14,534 404 -895 -
Tax Rate 6.38% - -27.78% -21.47% -160.21% -52.86% - -
Total Cost 9,913 45,660 24,076 2,030 64,916 65,684 58,314 -69.21%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin 64.72 -38.92 8.69 95.38 -28.85 0.61 -1.56 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS 1.04 -0.74 0.13 2.46 -0.86 0.02 -0.05 -
EPS Diluted 1.03 -0.74 0.13 2.33 -0.86 0.02 -0.05 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.